000724434 000__ 05059cam\a2200541Ii\4500
000724434 001__ 724434
000724434 005__ 20230306140533.0
000724434 006__ m\\\\\o\\d\\\\\\\\
000724434 007__ cr\cn\nnnunnun
000724434 008__ 141120t20142015gw\a\\\\ob\\\\000\0\eng\d
000724434 019__ $$a902313522$$a908084782
000724434 020__ $$a9783642370991$$qelectronic book
000724434 020__ $$a3642370993$$qelectronic book
000724434 020__ $$z9783642370984
000724434 020__ $$z3642370985 
000724434 035__ $$aSP(OCoLC)ocn896345263
000724434 035__ $$aSP(OCoLC)896345263$$z(OCoLC)902313522$$z(OCoLC)908084782
000724434 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dN$T$$dGW5XE$$dOCLCF$$dYDXCP$$dOCLCA$$dIDEBK$$dEBLCP$$dOCLCO
000724434 049__ $$aISEA
000724434 050_4 $$aRC280.P7
000724434 08204 $$a616.99463$$223
000724434 24500 $$aRadiotherapy in prostate cancer$$h[electronic resource] :$$binnovative techniques and current controversies /$$cHans Geinitz, Mack Roach III, Nicholas van As, editors.
000724434 264_1 $$aBerlin :$$bSpringer-Verlag,$$c[2014]
000724434 264_4 $$c©2015
000724434 300__ $$a1 online resource :$$billustrations.
000724434 336__ $$atext$$btxt$$2rdacontent
000724434 337__ $$acomputer$$bc$$2rdamedia
000724434 338__ $$aonline resource$$bcr$$2rdacarrier
000724434 4901_ $$aMedical radiology. Radiation oncology
000724434 504__ $$aIncludes bibliographical references.
000724434 5050_ $$aAcknowledgments; Contents; Contributors; Part I Imaging, Delineation and Immobilization; 1034 MR Imaging and MR Spectroscopy in Prostate Cancer; Abstract; 1 The Role of Magnetic Resonance Imaging (MRI) in the Diagnosis and Therapy Monitoring of Prostate Cancer (PCa); 2 Multiparametric MRI (mp-MRI); 2.1 T2-Weighted Imaging; 2.2 Diffusion-Weighted Imaging (DWI) and the Apparent Diffusion Coefficient (ADC); 2.3 Dynamic-Contrast-Enhanced MRI (DCE-MRI, Perfusion Imaging); 2.4 MR Spectroscopy of Prostate Cancer; 2.4.1 1H-MR Spectrum and Metabolite Signals
000724434 5058_ $$a2.4.2 1H-MRS Acquisition and Spatial Localization2.4.3 MR Spectroscopic Imaging (MRSI); 2.4.4 MRSI of the Prostate in Radiotherapy Planning and Follow-Up; 3 Summary; References; 1007 PET/CT Imaging in Prostate Cancer: Indications and Perspectives for Radiation Therapy; Abstract; 1...Introduction; 2...Radiotracers; 2.1 11C-Choline, 18F-Choline; 2.2 11C-Acetate; 2.3 18F-Fluorodeoxyglucose (FDG); 2.4 18F-Fluoride; 2.5 Other Tracers; 3...Hardware and Technical Considerations; 4...PET/CT-Imaging of PCa in the primary situation; 4.1 Determining T-Stage; 4.1.1 11C-Choline; 4.1.2 18F-Choline; 4.2 N-Staging
000724434 5058_ $$a4.2.1 11C-Choline4.2.2 18F-Choline; 4.3 M-Staging; 4.3.1 11C-Choline; 4.3.2 18F-Choline; 5...PET/CT-Imaging of Recurrent PCa; 5.1 11C-Choline; 5.2 18F-Choline; 6...Summary of Data, Recommendations, and Perspectives; 6.1 Primary PCa; 6.2 PSA Recurrence; 6.3 Perspectives in the Situation of Relapse with Locoregional Lymphnode Metastases; 6.4 Therapy Monitoring; 6.5 Closing Remarks; References; 958 Target Volume Definition in Primary Prostate Cancer Radiotherapy; Abstract; 1...Introduction; 2...International Commission on Radiation Units and Measurement (ICRU) Volumes Definition
000724434 5058_ $$a3...Pathological Considerations for Prostate Cancer Clinical Target Volume Delineation3.1 CTV Delineation in Low-Risk Prostate Cancer; 3.2 CTV Delineation in Intermediate- and High-Risk Prostate Cancer; 4...CT/MRI and Target Delineation; 5...CTV-PTV Margin; References; 1008 Value of Patient Immobilization in External Beam Radiotherapy for Prostate Cancer; Abstract; 1...Introduction; 2...Patient Positioning and External Patient Immobilization; 3...Internal Prostate Immobilization Strategies; 4...Conclusions; References; 917 Internal Immobilization: From Rectal Balloon to Hyaluronic Acid; Abstract
000724434 5058_ $$a1...Introduction2...Endorectal Balloon; 2.1 Products; 2.2 Application and Patient's Tolerance; 2.3 Immobilization; 2.4 Reproducibility; 2.5 Radioprotection of the Rectum/Rectal Wall; 2.6 Impact on Rectal Toxicity; 2.7 Summary; 3...Rectal Spacer: Hyaluronic Acid (HA), Space OAR Gel, Biodegradable Balloon; 3.1 Products; 3.2 Application; 3.3 Reproducibility/Stability and Radioprotection of the Rectum/ Rectal Wall; 3.4 Summary; References; Part II Clinical Endpoints; 904 Biochemical Recurrence: A Valuable Endpoint?; Abstract; 1...Definition of Biochemical Failure
000724434 506__ $$aAccess limited to authorized users.
000724434 520__ $$aThis book examines in detail the role of innovative radiation techniques in the management of prostate cancer, including IMRT, IGRT, BART, and modern brachytherap. It also explores a range of current controversies in patient treatment.
000724434 588__ $$aDescription based on print version record.
000724434 650_0 $$aProstate$$xCancer$$xRadiotherapy.
000724434 7001_ $$aGeinitz, Hans,$$eeditor.
000724434 7001_ $$aRoach, Mack,$$cIII,$$eeditor.
000724434 7001_ $$aVan As, Nicholas,$$eeditor.
000724434 77608 $$iPrint version:$$tRadiotherapy in Prostate Cancer$$z3642370985$$w(OCoLC)858680580
000724434 830_0 $$aMedical radiology (Series)
000724434 852__ $$bebk
000724434 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-642-37099-1$$zOnline Access$$91397441.1
000724434 909CO $$ooai:library.usi.edu:724434$$pGLOBAL_SET
000724434 980__ $$aEBOOK
000724434 980__ $$aBIB
000724434 982__ $$aEbook
000724434 983__ $$aOnline
000724434 994__ $$a92$$bISE